Stay updated on Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to opm.gov for updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-03T22:24:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    This update adds a glossary option and standardizes capitalization of metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') along with a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:01:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision update from v3.3.3 to v3.3.4; no visible changes to study content or page functionality detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T13:55:36.000Z thumbnail image
  4. Check
    48 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include entries for California, Michigan, Pennsylvania, and Virginia, and the revision tag updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-22T21:45:42.000Z thumbnail image
  5. Check
    69 days ago
    Change Detected
    Summary
    The page shows a revision update to v3.3.2, replacing the previous v3.3.1. No substantive study details, eligibility criteria, endpoints, or enrollment changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:48:36.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision history updated from v3.2.0 to v3.3.1; no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T10:55:35.000Z thumbnail image

Stay in the know with updates to Grapiprant and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Grapiprant and Pembrolizumab in NSCLC Clinical Trial page.